Share this article
BTC
$90,349.31
+
2.20%ETH
$1,647.77
+
0.45%USDT
$1.0002
+
0.02%XRP
$2.1325
-
0.07%BNB
$609.26
+
0.72%SOL
$143.88
+
2.46%USDC
$0.9999
+
0.01%DOGE
$0.1691
+
4.11%ADA
$0.6546
+
1.31%TRX
$0.2452
+
0.89%LINK
$13.63
+
0.59%AVAX
$20.62
-
0.04%LEO
$8.9401
-
1.32%XLM
$0.2543
-
2.69%SUI
$2.3765
+
4.96%SHIB
$0.0₄1295
+
2.29%HBAR
$0.1755
+
2.03%TON
$2.9478
-
2.26%BCH
$351.12
+
1.80%HYPE
$18.86
+
2.70%Sign Up
- Back to menuPrices
- Back to menuResearch
- Back to menuConsensus
- Back to menu
- Back to menu
- Back to menu
- Back to menuWebinars & Events
Medical Data Company OneMedNet Latest to Pursue Bitcoin Treasury Strategy After Capital Raise
Crypto investment fund Off the Chain Capital Management was among the investors in a private placement that funded the bitcoin purchase.
- Crypto fund Off The Chain Capital made more than a million dollar investment into medical data company OneMedNet so that it could buy bitcoin.
- The fund hopes to outperform the price of bitcoin through its investments by buying it for a discount through allocations like this.
OneMedNet (ONMD) late last month raised $4.6 million in a private placement and used $1.8 million of the proceeds to purchase bitcoin BTC$90,186, according to a press release.
Among the investors was Off The Chain Capital, a crypto investment fund with ties to Bloq Chairman Matthew Roszak and Fortress founder Rob Kauffman, which purchased a combination of shares and warrants in ONMD.
STORY CONTINUES BELOW
OneMedNet has seen its stock price fall more than 90% since it came public via a SPAC deal late last year.
“It’s an opportunity that if it works correctly, it can outperform bitcoin’s performance,” Brian Dixon, CEO of Off The Chain Capital told CoinDesk. “From our goal as an investor, we’re looking for these discount or value opportunities and we work really hard to try to outperform bitcoin.”
Dixon believes that it is crucial for public companies to reinvest some of their cash into bitcoin, rather than real estate, stocks or bonds, in order to add the most shareholder value.
“I think more and more public companies are going to wake up to the fact that if you don’t have bitcoin on your balance sheet, you’re not being intelligent as a fiduciary to that additional cash flow you have in terms of where you allocate this part of your treasury reserve strategy," he said.
In this, Off the Chain and OneMedNet is making a similar argument to that of Michael Saylor, whose MicroStrategy (MSTR) has seen its stock price outperform the return of bitcoin since the company began adding the crypto to its balance sheet in August 2020.
U.S.-listed Semler Scientific and Japan's Metaplanet are among other publicly traded companies pursuing similar strategies.
Read more: Metaplanet Arranges Loan to Buy $6.8M of BTC
Helene Braun
Helene is a New York-based markets reporter at CoinDesk, covering the latest news from Wall Street, the rise of the spot bitcoin exchange-traded funds and updates on crypto markets. She is a graduate of New York University's business and economic reporting program and has appeared on CBS News, YahooFinance and Nasdaq TradeTalks. She holds BTC and ETH.
